The biochemical definition of subclinical hypothyroidism (SH) is an elevation of serum Thyroid stimulating hormone (TSH) or thyrotropin level with the associated triioditroponin (T3) and thyroxine (T4) levels in normal reference range. If not prevented at the initial phase, SH eventually progresses into overt hypothyroidism thereby taking a massive toll on the human health. With the advancement of alternative science over the recent decades, a novel pain-free approach has been discussed that successfully treats SH within a span of two months. In this case study, a 23-year old woman reports severe fatigue, mild mood swings and constipation. Physical examination denotes no enlargement of the thyroid gland. However, laboratory results report an elevated serum TSH of 9.85 μIU/mL (reference range: 0.39-6.16 μIU/mL) with normal free T3 (1.79 ng/ml, reference range: 0.52-1.85 ng/ml) and T4(10.17 μIU/mL, reference range: 4.6-11.2 μIU/mL) levels. To prevent the progression of the condition, “Neurotherapy” treatment is provided to the patient. The study sought to determine whether this unique treatment was effective for a patient with SH. Post therapy, laboratory results show a significant reduction of the serum TSH with no associated side-effects, thereby confirming the effectiveness of neurotherapy treatment for the prevention and further progression of this condition.
Javed Z, Sathyapalan T. Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefits. Ther Adv Endocrinol Metab 2016; 7(1): 12–23.
Peeters RP. Subclinical Hypothyroidism. N Engl J Med 2017; 377(14): 1404.
Biondi B, Cappola AR, Cooper DS. Subclinical Hypothyroidism: A Review. JAMA 2019; 322(2): 153–60.
Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo ClinProc 2009; 84(1): 65–71.
Sue LY, Leung AM. Levothyroxine for the Treatment of Subclinical Hypothyroidism and Cardiovascular Disease. Front Endocrinol 2020; 11: 591588.
Peeters RP. Subclinical Hypothyroidism. N Engl J Med 2017; 376(26): 2556–2565.
Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. ClinEndocrinol 1995; 43(1): 55–68.
Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. ClinEndocrinol 2004; 61(2): 232–8.
Takashima N, Niwa Y, Mannami T, Tomoike H, Iwai N. Characterization of subclinical thyroid dysfunction from cardiovascular and metabolic viewpoints: the Suita study. Circ J 2007; 71(2): 191–5.
Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995; 43(1): 55–68.
Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 2002; 87(7): 3221–6.
Gandhi A, Singh L. Impact of neurotherapy treatment on knee pain. Integrative Medicine Case Reports 2020; 1(1): 11–12.
Dev D, Dutta P. A novel approach to treat polycystic ovarian syndrome (PCOS) patients. Biomedicine 2022; 42(4): 841–3.
Gopal R, Gandhi A. Impact of neurotherapy treatment in pain relief among patients having low back pain. Int J Indian Psychol 2023; 11(3): 110–17.